Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
APCCMI November 2 – 4, 2025 Bangkok, Thailand
, /in Events /by panglobalNovember 2 – 4, 2025 Bangkok, Thailand www.apccmi2025.com
ESPT Congress November 5 – 8, 2025 Rotterdam, Netherlands www.esptcongress.org
, /in Events /by panglobalNovember 5 – 8, 2025 Rotterdam, Netherlands
respons®A1c – The most convenient way of reliable diabetes management.
, /in Advertenties /by panglobalDiabetes requires constant monitoring through accurate and reliable testing.
Accuracy 365 – Online Quality Control
, /in Advertenties /by panglobalAccuracy 365 aims to monitor and compare, between laboratories, the results obtained in the Internal Quality Control processes of end-users of specific protein control materials manufactured by TRIMERO Diagnostics.
SHIMADZU excellence in Science
, /in Advertenties /by panglobalCLAM-2040 goes live with RECIPE TDM platform
Genomize and Genomenon forge alliance to transform genomic data interpretation capabilities
, /in E-News /by panglobalIn a significant development for genomic analysis capabilities, bioinformatics solutions provider Genomize has partnered with genomic intelligence company Genomenon to incorporate curated genomic data into its SEQ Platform. The collaboration will integrate Genomenon’s Mastermind Genomic Intelligence Platform and Cancer Knowledge Base (CKB) into Genomize’s analysis workflow.
IDS & EUROIMMUN | Hand in hand for powerful endocrinology
, /in Advertenties /by panglobalHand in hand for powerful endocrinology
Nuage Therapeutics appoints new leadership to advance oncogenic transcription factor therapies
, /in E-News /by panglobalBarcelona-based Nuage Therapeutics has announced key leadership appointments with Dr. Stuart Hughes joining as CEO and Vanessa Malier as Chair, as the company advances its platform for targeting previously undruggable oncogenic transcription factors through novel technology addressing intrinsically disordered proteins.
Leadership transition at ProBioGen marks strategic shift in biologics development sector
, /in E-News /by panglobalDr. Alfred Merz has been appointed Chief Executive Officer at Berlin-based ProBioGen, a contract development and manufacturing organisation specialising in biopharmaceuticals, viral vectors and vaccines. The appointment signals a strategic realignment within the company as it seeks to leverage Dr. Merz’s extensive pharmaceutical background to accelerate growth in the competitive biologics market.
Source BioScience expands diagnostic capabilities with acquisition of Cambridge Clinical Laboratories
, /in E-News /by panglobalSource BioScience UK Ltd has completed the acquisition of Cambridge Clinical Laboratories (CCL), establishing a more comprehensive clinical diagnostics portfolio that aims to streamline testing services across the research and clinical spectrum. The transaction, announced on 10 April 2025, will see CCL staff and assets relocated to new clinical laboratory facilities at Source BioScience’s Vision […]